Therefore, further optimization is needed to increase the effectiveness of vagal modulation
Tirzepatide is an innovative medication that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
When Harvard researchers recently reviewed over two decades of data from more than 115,000 people, they found that Surprisingly, even replacing just 1 percent of those fats with the same number of calories from polyunsaturated fats, whole grains, or plant proteins lowered the risk by 6 to 8 percent
Tex Heart Inst J 18(1):41 Bogle C, Colan SD, Miyamoto SD, Choudhry S, Baez-Hernandez N, Brickler MM, Feingold B, Lal AK, Lee TM, Canter CE, Lipshultz SE (2023) Treatment strategies for cardiomyopathy in children: a scientific statement from the American Heart Association